Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Apremilast as an adjuvant therapy for calcinosis cutis.

Qiblawi SH, Fivenson DP.

JAAD Case Rep. 2019 Sep 25;5(10):874-876. doi: 10.1016/j.jdcr.2019.08.006. eCollection 2019 Oct. No abstract available.

2.

Pyoderma gangrenosum, acne, and hidradenitis suppurativa (PASH) syndrome with recurrent vasculitis.

Niv D, Ramirez JA, Fivenson DP.

JAAD Case Rep. 2017 Feb 4;3(1):70-73. doi: 10.1016/j.jdcr.2016.11.006. eCollection 2017 Jan. No abstract available.

3.

Linear scleroderma in an adolescent woman treated with methotrexate and excimer laser.

Hanson AH, Fivenson DP, Schapiro B.

Dermatol Ther. 2014 Jul-Aug;27(4):203-5. doi: 10.1111/dth.12117. Epub 2014 Feb 18.

PMID:
24548477
4.

A woman with amyloidosis, corneal dystrophy, and pruritic vesicular eruptions.

Hanson AH, Fivenson DP, Schapiro B.

J Am Acad Dermatol. 2013 Feb;68(2):e56-7. doi: 10.1016/j.jaad.2012.09.009. No abstract available.

PMID:
23317993
5.

Efficacy and safety of denileukin diftitox retreatment in patients with relapsed cutaneous T-cell lymphoma.

Duvic M, Martin AG, Olsen EA, Fivenson DP, Prince HM.

Leuk Lymphoma. 2013 Mar;54(3):514-9. doi: 10.3109/10428194.2012.720372. Epub 2012 Sep 3.

PMID:
22891708
6.

Denileukin diftitox for the treatment of CD25 low-expression mycosis fungoides and S├ęzary syndrome.

Prince HM, Martin AG, Olsen EA, Fivenson DP, Duvic M.

Leuk Lymphoma. 2013 Jan;54(1):69-75. doi: 10.3109/10428194.2012.706286. Epub 2012 Sep 14.

7.

Phaeohyphomycosis caused by Phaeoacremonium species in a patient taking infliximab.

Mazzurco JD, Ramirez J, Fivenson DP.

J Am Acad Dermatol. 2012 Feb;66(2):333-5. doi: 10.1016/j.jaad.2010.04.015. No abstract available.

PMID:
22243731
8.

Localized mycosis fungoides of the bilateral thumbs and nail units treated with orthovoltage radiation.

Mazzurco JD, Schapiro BL, Fivenson DP.

Int J Dermatol. 2010 Nov;49(11):1334-5. doi: 10.1111/j.1365-4632.2010.04649.x. No abstract available.

PMID:
20964661
9.

Etanercept improves psoriatic arthritis patient-reported outcomes: results from EDUCATE.

Frankel EH, Strober BE, Crowley JJ, Fivenson DP, Woolley JM, Yu EB, Xia HA, Chiou CF, Stevens SR.

Cutis. 2007 Apr;79(4):322-6.

PMID:
17500381
10.

An open-label study of topical tacrolimus ointment 0.1% under occlusion for the treatment of pyoderma gangrenosum.

Kontos AP, Kerr HA, Fivenson DP, Remishofsky C, Jacobsen G.

Int J Dermatol. 2006 Nov;45(11):1383-5. No abstract available.

PMID:
17076739
11.

Chemokine and inflammatory cytokine changes during chronic wound healing.

Fivenson DP, Faria DT, Nickoloff BJ, Poverini PJ, Kunkel S, Burdick M, Strieter RM.

Wound Repair Regen. 1997 Oct-Dec;5(4):310-22.

12.

The mechanisms of action of nicotinamide and zinc in inflammatory skin disease.

Fivenson DP.

Cutis. 2006 Jan;77(1 Suppl):5-10. Review.

PMID:
16871773
13.

308-nm excimer laser for the treatment of lymphomatoid papulosis and stage IA mycosis fungoides.

Kontos AP, Kerr HA, Malick F, Fivenson DP, Lim HW, Wong HK.

Photodermatol Photoimmunol Photomed. 2006 Jun;22(3):168-71. No abstract available.

PMID:
16719874
14.

Treatment of generalized lichen planus with alefacept.

Fivenson DP, Mathes B.

Arch Dermatol. 2006 Feb;142(2):151-2. No abstract available.

PMID:
16490842
15.

Immunoglobulin M predominance in cutaneous lupus erythematosus.

Kontos AP, Jirsari M, Jacobsen G, Fivenson DP.

J Cutan Pathol. 2005 May;32(5):352-5.

PMID:
15811120
16.

Lepromatous phlebitis of the external jugular vein.

Thompson AM, Lynn AA, Robson K, Joyce MP, Fivenson DP, Scollard D.

J Am Acad Dermatol. 2003 Dec;49(6):1180-2.

PMID:
14639414
17.

Apligraf in the treatment of severe mitten deformity associated with recessive dystrophic epidermolysis bullosa.

Fivenson DP, Scherschun L, Cohen LV.

Plast Reconstr Surg. 2003 Aug;112(2):584-8. No abstract available.

PMID:
12900618
18.

Graftskin therapy in epidermolysis bullosa.

Fivenson DP, Scherschun L, Choucair M, Kukuruga D, Young J, Shwayder T.

J Am Acad Dermatol. 2003 Jun;48(6):886-92.

PMID:
12789180
19.

A complete and durable response to denileukin diftitox in a patient with mycosis fungoides.

Carretero-Margolis CD, Fivenson DP.

J Am Acad Dermatol. 2003 Feb;48(2):275-6.

PMID:
12582402
20.

Narrowband UVB phototherapy for early-stage mycosis fungoides.

Gathers RC, Scherschun L, Malick F, Fivenson DP, Lim HW.

J Am Acad Dermatol. 2002 Aug;47(2):191-7.

PMID:
12140464
21.

Clotrimazole/betamethasone diproprionate: a review of costs and complications in the treatment of common cutaneous fungal infections.

Greenberg HL, Shwayder TA, Bieszk N, Fivenson DP.

Pediatr Dermatol. 2002 Jan-Feb;19(1):78-81. Review.

PMID:
11860579
22.

Leg ulcer diagnosis and management.

Choucair MM, Fivenson DP.

Dermatol Clin. 2001 Oct;19(4):659-78, viii. Review.

PMID:
11705353
23.

Ulcerating plantar keratoderma in association with systemic lupus erythematosus.

Grossberg EB, Scherschun L, Fivenson DP.

Lupus. 2001;10(9):650-2.

PMID:
11678455
24.

Eosinophilic dermatosis of myeloproliferative disease: characterization of a unique eruption in patients with hematologic disorders.

Byrd JA, Scherschun L, Chaffins ML, Fivenson DP.

Arch Dermatol. 2001 Oct;137(10):1378-80. Review. No abstract available.

PMID:
11594874
25.
26.

Lupus profundus: not a benign disease.

Grossberg E, Scherschun L, Fivenson DP.

Lupus. 2001;10(7):514-6.

PMID:
11480852
27.

Clinical trial: the safety of terbinafine in patients over the age of 60 years: a multicenter trial in onychomycosis of the feet.

Smith EB, Stein LF, Fivenson DP, Atillasoy ES.

Int J Dermatol. 2000 Nov;39(11):861-4.

PMID:
11123452
28.

Generalization of cicatricial pemphigoid during azathioprine therapy.

Burgess MJ, Fivenson DP.

Arch Dermatol. 2000 Oct;136(10):1274. No abstract available.

PMID:
11030786
29.

Capillary leak syndrome in a patient treated with interleukin 2 fusion toxin for cutaneous T-cell lymphoma.

Railan D, Fivenson DP, Wittenberg G.

J Am Acad Dermatol. 2000 Aug;43(2 Pt 1):323-4. No abstract available.

PMID:
10906662
30.

Lichenoid dermatitis in paraneoplastic pemphigus: a pathogenic trigger of epitope spreading?

Bowen GM, Peters NT, Fivenson DP, Su LD, Nousari HC, Anhalt GJ, Cooper KD, Stevens SR.

Arch Dermatol. 2000 May;136(5):652-6.

PMID:
10815859
31.

Prospective, single-blind, randomized, controlled study to assess the efficacy of the 585-nm flashlamp-pumped pulsed-dye laser and silicone gel sheeting in hypertrophic scar treatment.

Wittenberg GP, Fabian BG, Bogomilsky JL, Schultz LR, Rudner EJ, Chaffins ML, Saed GM, Burns RL, Fivenson DP.

Arch Dermatol. 1999 Sep;135(9):1049-55.

PMID:
10490109
32.

p53 and apoptosis alterations in keloids and keloid fibroblasts.

Ladin DA, Hou Z, Patel D, McPhail M, Olson JC, Saed GM, Fivenson DP.

Wound Repair Regen. 1998 Jan-Feb;6(1):28-37.

PMID:
9776848
33.

Nonsteroidal treatment of autoimmune skin diseases.

Fivenson DP.

Dermatol Clin. 1997 Oct;15(4):695-705. Review.

PMID:
9348470
34.

Lichen planus pemphigoides: combination therapy with tetracycline and nicotinamide.

Fivenson DP, Kimbrough TL.

J Am Acad Dermatol. 1997 Apr;36(4):638-40. No abstract available.

PMID:
9092758
35.

Glycolic acid peels for postinflammatory hyperpigmentation in black patients. A comparative study.

Burns RL, Prevost-Blank PL, Lawry MA, Lawry TB, Faria DT, Fivenson DP.

Dermatol Surg. 1997 Mar;23(3):171-4; discussion 175.

PMID:
9145958
36.

T-cell cytokine network in cutaneous lupus erythematosus.

Stein LF, Saed GM, Fivenson DP.

J Am Acad Dermatol. 1997 Feb;36(2 Pt 1):191-6.

PMID:
9039167
37.

Cytokine mRNA changes during the treatment of hypertrophic scars with silicone and nonsilicone gel dressings.

Ricketts CH, Martin L, Faria DT, Saed GM, Fivenson DP.

Dermatol Surg. 1996 Nov;22(11):955-9.

PMID:
9063511
38.

Evidence against a role for human T-cell lymphotrophic virus type I (HTLV-I) in the pathogenesis of American cutaneous T-cell lymphoma.

Wood GS, Salvekar A, Schaffer J, Crooks CF, Henghold W, Fivenson DP, Kim YH, Smoller BR.

J Invest Dermatol. 1996 Sep;107(3):301-7.

39.

Absence of human T-cell lymphotropic virus genomic determinants in canine mycosis fungoides.

Fivenson DP, Schaffer J, Saed G, Beck ER, Wood GS.

Arch Dermatol. 1996 Jul;132(7):841-2. No abstract available.

PMID:
8678587
41.
42.

Localization of clonal T cells to the epidermis in cutaneous T-cell lymphoma.

Fivenson DP, Hanson CA, Nickoloff BJ.

J Am Acad Dermatol. 1994 Nov;31(5 Pt 1):717-23.

PMID:
7929915
43.

Keratinocyte interleukin-10 expression is upregulated in tape-stripped skin, poison ivy dermatitis, and Sezary syndrome, but not in psoriatic plaques.

Nickoloff BJ, Fivenson DP, Kunkel SL, Strieter RM, Turka LA.

Clin Immunol Immunopathol. 1994 Oct;73(1):63-8.

44.

Quantitation of interferon gamma mRNA levels in psoralen/UVA-treated HUT-78 cells by competitive PCR.

Saed GM, Fivenson DP.

Biochem Biophys Res Commun. 1994 Sep 15;203(2):935-42.

PMID:
8093077
45.
46.

Nicotinamide and tetracycline therapy of bullous pemphigoid.

Fivenson DP, Breneman DL, Rosen GB, Hersh CS, Cardone S, Mutasim D.

Arch Dermatol. 1994 Jun;130(6):753-8.

PMID:
8002646
47.

Papulonodular dermal mucinosis in systemic lupus erythematosus.

Jackson BA, Norum RA, Lowe L, Fivenson DP.

J Rheumatol. 1994 May;21(5):940-1.

PMID:
8064739
48.

T-cell receptor gene rearrangement in canine mycosis fungoides: further support for a canine model of cutaneous T-cell lymphoma.

Fivenson DP, Saed GM, Beck ER, Dunstan RW, Moore PF.

J Invest Dermatol. 1994 Feb;102(2):227-30.

49.

Treatment of pemphigus and linear IgA dermatosis with nicotinamide and tetracycline: a review of 13 cases.

Chaffins ML, Collison D, Fivenson DP.

J Am Acad Dermatol. 1993 Jun;28(6):998-1000. No abstract available.

PMID:
8496464
50.

Differential expression of factor XIIIa and CD34 in cutaneous mesenchymal tumors.

Altman DA, Nickoloff BJ, Fivenson DP.

J Cutan Pathol. 1993 Apr;20(2):154-8.

Supplemental Content

Loading ...
Support Center